1. Home
  2. DYN vs SKWD Comparison

DYN vs SKWD Comparison

Compare DYN & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • SKWD
  • Stock Information
  • Founded
  • DYN 1984
  • SKWD 2007
  • Country
  • DYN United States
  • SKWD United States
  • Employees
  • DYN N/A
  • SKWD N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • SKWD Property-Casualty Insurers
  • Sector
  • DYN Health Care
  • SKWD Finance
  • Exchange
  • DYN Nasdaq
  • SKWD Nasdaq
  • Market Cap
  • DYN 1.9B
  • SKWD 2.3B
  • IPO Year
  • DYN 2020
  • SKWD 2023
  • Fundamental
  • Price
  • DYN $22.76
  • SKWD $46.14
  • Analyst Decision
  • DYN Strong Buy
  • SKWD Buy
  • Analyst Count
  • DYN 14
  • SKWD 13
  • Target Price
  • DYN $34.93
  • SKWD $63.09
  • AVG Volume (30 Days)
  • DYN 2.9M
  • SKWD 432.9K
  • Earning Date
  • DYN 10-28-2025
  • SKWD 10-29-2025
  • Dividend Yield
  • DYN N/A
  • SKWD N/A
  • EPS Growth
  • DYN N/A
  • SKWD 3.25
  • EPS
  • DYN N/A
  • SKWD 3.37
  • Revenue
  • DYN N/A
  • SKWD $1,335,358,000.00
  • Revenue This Year
  • DYN N/A
  • SKWD $17.72
  • Revenue Next Year
  • DYN N/A
  • SKWD $21.86
  • P/E Ratio
  • DYN N/A
  • SKWD $13.52
  • Revenue Growth
  • DYN N/A
  • SKWD 22.27
  • 52 Week Low
  • DYN $6.36
  • SKWD $41.28
  • 52 Week High
  • DYN $35.68
  • SKWD $65.05
  • Technical
  • Relative Strength Index (RSI)
  • DYN 74.02
  • SKWD 45.97
  • Support Level
  • DYN $23.05
  • SKWD $44.09
  • Resistance Level
  • DYN $25.00
  • SKWD $48.70
  • Average True Range (ATR)
  • DYN 1.00
  • SKWD 1.77
  • MACD
  • DYN 0.72
  • SKWD -0.13
  • Stochastic Oscillator
  • DYN 78.19
  • SKWD 30.64

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About SKWD Skyward Specialty Insurance Group Inc.

Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.

Share on Social Networks: